BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 13, Issue 10
  • This Article
Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Scientometrics
©The Author(s) 2025.
World J Clin Cases. Apr 6, 2025; 13(10): 101719
Published online Apr 6, 2025. doi: 10.12998/wjcc.v13.i10.101719
Table 2 The 10 foremost countries ranked by publication volume in glioblastoma nanomedicine research1
Country
Number of documents
China999
United States755
France293
Italy287
Spain162
South Korea115
India113
Australia109
1The table illustrates the quantity of documents published by each nation, with China and the United States leading.
This distribution identifies the main contributors to research and emphasizes the regions most committed to nanomedicine applications for glioblastoma therapy
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.